OXOS MEDICAL, INC. · CIK 1694304
OXOS MEDICAL, INC.
These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.
Filings
1
Original notices
1
Amendments
0
Activity
Dec 19, 2025
through Dec 19, 2025
through Dec 19, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot: how to read these fields
- Reported offering amount
- $28,207,000
- Reported exemptions
- Rule 506(b)
- Reported amount sold
- $10,706,990
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Related person name and locality match
Matches in stored disclosures are research leads. They do not establish common ownership or confirm identity.
- Parkway Co-Investment 10 (xAI) QP LP · CIK 2023654
- Parkway Co-Investment 12 (Figure Series C) LP · CIK 2055676
- Parkway Co-Investment 12 (Figure Series C) QP LP · CIK 2055687
- Parkway Co-Investment 13 (SBQ SF) LP · CIK 2103638
- Parkway Co-Investment 13 (SBQ SF) QP LP · CIK 2103637
Form D filings (1)
-
0001694304-25-000002D · Dec 19, 2025 · Other TechnologyOffering: $28,207,000Sold: $10,706,990